Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Cancer
|
January 18, 2026
Toripalimab plus concurrent chemoradiotherapy for recurrent nasopharyngeal carcinoma: A single-arm, phase 2 clinical trial
Zhehao Xiao, Zhongguo Liang, Hejing Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 26, 2024
Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study
Yang Liu, Jie Ma, Xiao-Yi Zeng, et al.
Translational Oncology
|
March 13, 2026
Precision management of radiotherapy interruption in locoregionally advanced nasopharyngeal carcinoma: Induction chemotherapy counteracts the survival impact in high-risk patients defined by a novel model
Wang-Jian Li, Fang Su, Li-Ting Ling, et al.
Innovation (Cambridge (Mass.))
|
January 28, 2025
Famitinib plus camrelizumab in patients with advanced colorectal cancer: Data from a multicenter, basket study
Luoyan Ai, Qian Li, Shilong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Anti-LAG-3 Antibody LBL-007 Plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial
Dongchen Sun, Gang Chen, Yu Chen, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
Med (New York, N.Y.)
|
February 20, 2026
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
Fei Han, Xing Lv, Yu-Juan Zhou, et al.
Cancer Letters
|
February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
Jinguan Lin, Song Qu, Kunyu Yang, et al.
Signal Transduction and Targeted Therapy
|
June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study
Ye Guo, Zhendong Li, Liqiong Xue, et al.
Cell Reports. Medicine
|
October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study
Yuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Cancer
|
January 18, 2026
Toripalimab plus concurrent chemoradiotherapy for recurrent nasopharyngeal carcinoma: A single-arm, phase 2 clinical trial
Zhehao Xiao, Zhongguo Liang, Hejing Huang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 26, 2024
Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study
Yang Liu, Jie Ma, Xiao-Yi Zeng, et al.
Translational Oncology
|
March 13, 2026
Precision management of radiotherapy interruption in locoregionally advanced nasopharyngeal carcinoma: Induction chemotherapy counteracts the survival impact in high-risk patients defined by a novel model
Wang-Jian Li, Fang Su, Li-Ting Ling, et al.
Innovation (Cambridge (Mass.))
|
January 28, 2025
Famitinib plus camrelizumab in patients with advanced colorectal cancer: Data from a multicenter, basket study
Luoyan Ai, Qian Li, Shilong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Anti-LAG-3 Antibody LBL-007 Plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial
Dongchen Sun, Gang Chen, Yu Chen, et al.
Oral Oncology
|
February 22, 2024
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
Qiu-Yan Chen, Shan-Shan Guo, Ying Luo, et al.
Med (New York, N.Y.)
|
February 20, 2026
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
Fei Han, Xing Lv, Yu-Juan Zhou, et al.
Cancer Letters
|
February 1, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
Jinguan Lin, Song Qu, Kunyu Yang, et al.
Signal Transduction and Targeted Therapy
|
June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study
Ye Guo, Zhendong Li, Liqiong Xue, et al.
Cell Reports. Medicine
|
October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study
Yuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Page
of 18